DIA: Driving Insights to Action
Science:Life Sciences
Co-author Dr. Jeffrey Sherman, Chief Medical Officer / Executive Vice President at Horizon Pharmaceuticals, and DIA’s liaison to the Clinical Trials Transformation Initiative, reviews The Rules of Engagement: CTTI Recommendations for Successful Collaborations Between Sponsors and Patient Groups Around Clinical Trials with Ron Bartek, Co-Founder and President of the Friedreich’s Ataxia Research Alliance.
More Episodes
DIA/Tufts CSDD Research: AI Saving Time in Drug Development
2025-01-17
646
2025-01-17
646
DIA: Your Partner in Life Sciences Training and Development
2024-11-06
402
2024-11-06
402
GPP Experts Explain Authorship Algorithm
2024-04-23
301
2024-04-23
301
"Dossier in the Cloud" Democratizing Global Access
2024-04-02
335
2024-04-02
335
DIA: A Place Where You Can Make a Difference
2024-03-28
274
2024-03-28
274
Retiring TGA Head Maps Australia’s Post-Pandemic Future
2023-07-17
409
2023-07-17
409
Patient Engagement: Evolution of Who Knows What, Part 2
2023-06-14
305
2023-06-14
305
Patient Engagement: Evolution of Who Knows What, Part 1
2023-06-12
443
2023-06-12
443
Rwanda Welcomes African Medicines Agency Home
2022-11-30
613
2022-11-30
613
Will Technology Solve the Research “People Problem”?
2022-11-22
384
2022-11-22
384
Why Trans/Nonbinary Research Benefits All Communities
2022-11-18
767
2022-11-18
767
Digital Revolutionizing Data-Driven Reimbursement
2022-10-20
410
2022-10-20
410
China Sets New Record for Local Drug Approvals in 2021
2022-09-15
443
2022-09-15
443
WHO Pilot Formalizes CSA Process to Assist Developers
2022-08-02
440
2022-08-02
440
Get this podcast on your
phone, FREE
